Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study

Yilin Chen & Josh J. Carlson et al. · 2024-03-26

Authors
Yilin Chen, Peter Martin, Lurdes Y.T. Inoue, Anirban Basu, Josh J. Carlson